LRPPRC and metabolic dysfunction-associated steatotic liver disease: Our results reveal that specific loss of LRPPRC in the liver does not lead to obesity but induces deleterious remodeling of the liver matrix with signs of fibrosis and impaired hepatic structure similar in both sexes recapitulating to some extent the lean-NAFLD phenotype in humans.